BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36910655)

  • 21. Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21.
    Capela de Matos RR; Othman M; Ferreira GM; Monteso K; de Souza MT; Rouxinol M; Melo JB; Carreira IM; Abdelhay E; Liehr T; Ribeiro RC; Silva M
    Cancer Genet; 2022 Apr; 262-263():16-22. PubMed ID: 34974289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy.
    Sinclair PB; Parker H; An Q; Rand V; Ensor H; Harrison CJ; Strefford JC
    Hum Mol Genet; 2011 Jul; 20(13):2591-602. PubMed ID: 21487021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia.
    Li Y; Schwab C; Ryan S; Papaemmanuil E; Robinson HM; Jacobs P; Moorman AV; Dyer S; Borrow J; Griffiths M; Heerema NA; Carroll AJ; Talley P; Bown N; Telford N; Ross FM; Gaunt L; McNally RJQ; Young BD; Sinclair P; Rand V; Teixeira MR; Joseph O; Robinson B; Maddison M; Dastugue N; Vandenberghe P; Stephens PJ; Cheng J; Van Loo P; Stratton MR; Campbell PJ; Harrison CJ
    Nature; 2014 Apr; 508(7494):98-102. PubMed ID: 24670643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.
    Moorman AV; Robinson H; Schwab C; Richards SM; Hancock J; Mitchell CD; Goulden N; Vora A; Harrison CJ
    J Clin Oncol; 2013 Sep; 31(27):3389-96. PubMed ID: 23940220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrachromosomal Amplification of Chromosome 21 in Childhood Acute Lymphoblastic Leukemia: Study of 3 Cases.
    Mroczkowska A; Lejman M
    Case Rep Oncol; 2021; 14(1):592-598. PubMed ID: 33976639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the RAS pathway in iAMP21-ALL.
    Ryan SL; Matheson E; Grossmann V; Sinclair P; Bashton M; Schwab C; Towers W; Partington M; Elliott A; Minto L; Richardson S; Rahman T; Keavney B; Skinner R; Bown N; Haferlach T; Vandenberghe P; Haferlach C; Santibanez-Koref M; Moorman AV; Kohlmann A; Irving JA; Harrison CJ
    Leukemia; 2016 Sep; 30(9):1824-31. PubMed ID: 27168466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
    Attarbaschi A; Panzer-Grümayer R; Mann G; Möricke A; König M; Mecklenbräuker A; Teigler-Schlegel A; Bradtke J; Harbott J; Göhring G; Stanulla M; Schrappe M; Zimmermann M; Haas OA;
    Klin Padiatr; 2014 Nov; 226(6-7):338-43. PubMed ID: 25431866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain.
    Sinclair PB; Ryan S; Bashton M; Hollern S; Hanna R; Case M; Schwalbe EC; Schwab CJ; Cranston RE; Young BD; Irving JAE; Vora AJ; Moorman AV; Harrison CJ
    Leukemia; 2019 Aug; 33(8):1881-1894. PubMed ID: 30816328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21.
    Verdoni AM; Zilla ML; Bullock G; Guinipero TL; Meade J; Yatsenko SA
    Am J Med Genet A; 2022 Aug; 188(8):2325-2330. PubMed ID: 35678493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RUNX1 deletion/amplification in therapy-related acute myeloid leukemia: A case report and review of the literature.
    Nguyen D; Li Y; Safah H; Brown TC
    Cancer Genet; 2019 Oct; 238():37-43. PubMed ID: 31425924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle.
    Robinson HM; Harrison CJ; Moorman AV; Chudoba I; Strefford JC
    Genes Chromosomes Cancer; 2007 Apr; 46(4):318-26. PubMed ID: 17243167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrachromosomal amplification of chromosome 21 (iAMP21) detected by ETV6/RUNX1 FISH screening in childhood acute lymphoblastic leukemia: a case report.
    Garcia DR; Arancibia AM; Ribeiro RC; Land MG; Silva ML
    Rev Bras Hematol Hemoter; 2013; 35(5):369-71. PubMed ID: 24255623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful hematopoietic stem cell transplantation for two patients with relapse of intrachromosomal amplification of chromosome 21-positive B-cell precursor acute lymphoblastic leukemia.
    Harada T; Toyoda H; Tsuboya N; Hanaki R; Amano K; Hirayama M
    Front Pediatr; 2022; 10():960126. PubMed ID: 36160794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).
    Moorman AV; Richards SM; Robinson HM; Strefford JC; Gibson BE; Kinsey SE; Eden TO; Vora AJ; Mitchell CD; Harrison CJ;
    Blood; 2007 Mar; 109(6):2327-30. PubMed ID: 17095619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study.
    Baughn LB; Biegel JA; South ST; Smolarek TA; Volkert S; Carroll AJ; Heerema NA; Rabin KR; Zweidler-McKay PA; Loh M; Hirsch B
    Cancer Genet; 2015; 208(1-2):1-18. PubMed ID: 25678190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of intrachromosomal amplification of chromosome 21 on outcome in pediatric acute lymphoblastic leukemia: Does it affect our patients too?
    Al-Sweedan S; Altahan R
    Hematol Rep; 2019 May; 11(2):7826. PubMed ID: 31285807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease.
    Harrison CJ
    Blood; 2015 Feb; 125(9):1383-6. PubMed ID: 25608562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
    Staaf J; Jönsson G; Ringnér M; Baldetorp B; Borg A
    Breast Cancer Res; 2011; 13(6):R129. PubMed ID: 22169037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.
    Moorman AV; Ensor HM; Richards SM; Chilton L; Schwab C; Kinsey SE; Vora A; Mitchell CD; Harrison CJ
    Lancet Oncol; 2010 May; 11(5):429-38. PubMed ID: 20409752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.